Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

How AstraZeneca Will Use A Diagnostic To Market Its Blood Thinner
Forbes
Fri, 03/22/13 - 10:38 am
Tags:
bloodthinners, AstraZeneca, Brilinta
Can Pascal Soriot Turn Around AstraZeneca? It May Come Down To One Drug
Forbes
Thu, 03/21/13 - 11:13 am
Tags:
Pascal Soriot, AstraZeneca, Pharma CEOs, Brilinta
No Quick Fixes, But Astra's Soriot Can Still Be Bold
Seeking Alpha
Tue, 03/19/13 - 10:41 am
Tags:
AstraZeneca, Pascal Soriot, restructuring
AstraZeneca restructuring will eliminate 1,600 jobs in US, UK and relocate global HQ by 2016
Yahoo/AP
Tue, 03/19/13 - 10:38 am
Tags:
AstraZeneca, restructuring, layoffs
AstraZeneca sees R&D restructuring to result in $1.4B in charges
Yahoo/Fly on the Wall
Mon, 03/18/13 - 11:00 am
Tags:
R&D, AstraZeneca, restructuring
Why AstraZeneca Will Disappoint In 2013
Seeking Alpha
Mon, 03/18/13 - 10:51 am
Tags:
AstraZeneca, AbbVie, Bristol-Myers Squibb, Merck, Pfizer, Nektar
Longer Lasting Drugs Make For Longer Lasting Profits
Seeking Alpha
Fri, 03/15/13 - 10:54 am
Tags:
AntriaBio, AstraZeneca, Novo Nordisk, Sanofi, Bristol-Myers Squibb
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
Tags:
breast cancer, aromatase inhibitors, AstraZeneca, Novartis, Femara, Arimidex, SERMs, Nolvadex, Roche, Herceptin, GSK, Tykerb, Xeloda, Perjeta, Kadcyla, Immunogen, Lymphoseek, Navidea Biopharmaceuticals, Nexavar, ONYX Pharmaceuticals
Puma Biotechnology Priced Like Takeover Target: Real M&A
Bloomberg
Tue, 03/12/13 - 11:26 am
Tags:
Puma Biotechnology, M&A, AstraZeneca, Bristol-Myers Squibb, Takeda, Celgene, GSK
A Deal For Pozen's PA Could Send Shares Soaring
Seeking Alpha
Thu, 03/7/13 - 11:34 am
Tags:
Pozen, GSK, vivmo, AstraZeneca
AstraZeneca Pharma hits 52-week low on promoter stake sale plan
Business Standard, India
Wed, 03/6/13 - 10:54 am
Tags:
AstraZeneca
Targacept, AstraZeneca amend terms of collaboration
Bizjournals.com
Tue, 03/5/13 - 11:22 am
Tags:
Targacept, AstraZeneca, Alzheimer's disease, TC-1734
AstraZeneca Steady After Patent Setback
Motley Fool
Tue, 03/5/13 - 10:33 am
Tags:
AstraZeneca, patents, Crestor, Australia
Who's the Frailest Big Pharma of All?
Motley Fool
Sat, 03/2/13 - 04:08 pm
Tags:
Bristol-Myers Squibb, AstraZeneca, Pfizer, Eli Lilly, Sanofi
How Serious Is This News for Diabetes Drugmakers?
Motley Fool
Sat, 03/2/13 - 04:00 pm
Tags:
pancreatitis, diabetes, type 2 diabetes, Merck, AstraZeneca, Bristol-Myers Squibb
It's Time for This Big Pharma to Save Its Future
Motley Fool
Wed, 02/27/13 - 12:11 pm
Tags:
AstraZeneca
Atherosclerosis and the New Gold Standard
Yahoo/Accesswired
Tue, 02/26/13 - 10:29 am
Tags:
atherosclerosis, statins, Pfizer, Merck, AstraZeneca, AtheroNova, AHRO-001
AstraZeneca Inks Deal
Yahoo/Zacks
Sat, 02/16/13 - 11:41 am
Tags:
AstraZeneca
Shire to Forest on Deal List for AstraZeneca: Real M&A
Bloomberg
Tue, 02/12/13 - 12:13 pm
Tags:
Shire, Forest Labs, AstraZeneca, M&A
What Will Type 2 Diabetes Treatments Look Like in 5 Years?
Motley Fool
Wed, 02/6/13 - 08:34 am
Tags:
diabetes, Merck, SGLT2 inhibitor, Bristol-Myers Squibb, AstraZeneca, JNJ, Array Biopharma, Januvia, Amgen, Forixga, GKAs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.